Non-synonymous variants in the AMACR gene are associated with schizophrenia

Schizophrenia Research

Volumn 124, Issue 1-3, 2010, Pages 208-215

  Bespalova, Irina N ^a,b   Durner, Martina ^a,b   Ritter, Benjamin P ^a,b   Angelo, Gary W ^a,b   Rossy Fullana, Enrique ^c   Carrion Baralt, Jose ^d   Schmeidler, James ^a   Silverman, Jeremy M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c San Juan Veterans Affairs Medical Center   (Puerto Rico)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

5p13; AMACR; Case control study; Genetic association; Schizophrenia

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

3' FLANKING REGION; 5' FLANKING REGION; ADULT; ALLELES; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; OPEN READING FRAMES; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PUERTO RICO; RACEMASES AND EPIMERASES; SCHIZOPHRENIA; SEX FACTORS; SIBLINGS;

EID: 78249278157     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.08.040     Document Type: Article

References (71)

1. Aleman A., Kahn R.S., Selten J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 2003, 60(6):565-571.
2. Barak Y., Achiron A., Mandel M., Mirecki I., Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005, 104:2817-2821.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Bellivier F. Schizophrenia, antipsychotics and diabetes: Genetic aspects. Eur. Psychiatry 2005, (Suppl 4):S335-S339. Review.
5. Bespalova I.N., Angelo G.W., Smith C.J., Durner M., Siever L.J., Carrion-Baralt J., Buxbaum J.D., Silverman J.M. Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family. Psychiatr. Genet. 2005, 15:205-210.
6. Boekema E.J., Braun H.P. Supramolecular structure of the mitochondrial oxidative phosphorylation system. J. Biol. Chem. 2007, 282(1):1-4.
7. Bremer J. The biochemistry of hypoand hyperlipidemic fatty acid derivatives: metabolism and metabolic effects. Prog. Lipid Res. 2001, 40(4):231-268.
8. Breslow N.E., Day N.E. Statistical methods in cancer research, 1, the analysis of case-control studies 1980, International Agency for Research on Cancer, Lyon.
9. Clarke C.E., Alger S., Preece M.A., Burdon M.A., Chavda S., Denis S., Ferdinandusse S., Wanders R.J.A. Tremor and deep white matter changes in α-methylacyl-CoA racemase deficiency. Neurology 2004, 63(1):188-189.
10. Cooper-Casey K., Mesen-Fainardi A., Galke-Rollins B., Llach M., Laprade B., Rodriguez C., Riondet S., Bertheau A., Byerley W. Suggestive linkage of schizophrenia to 5p13 in Costa Rica. Mol. Psychiatry 2005, 10(7):651-656.
11. Coulombe-Huntington J., Lam K.C., Dias C., Majewski J. Fine-scale variation and genetic determinants of alternative splicing across individuals. PLoS Genet. 2009, 5(12):e1000766.
12. Crowe R.R., Vieland V. Report of the Chromosome 5 Workshop of the Sixth World Congress on Psychiatric Genetics. Am. J. Med. Genet. 1999, 88(3):229-232.
13. Cuebas D.A., Phillips C., Schmitz W., Conzelmann E., Novikov D.K. The role of alpha-methylacyl-CoA racemase in bile acid synthesis. Biochem. J. 2002, 363:801-807.
14. Danielyan A., Nasrallah H.A. Neurological disorders in schizophrenia. Psychiatr. Clin. North Am. 2009, 32(4):719-757.
15. Daugherty S.E., Platz E.A., Shugart Y.Y., Fallin M.D., Isaacs W.B., Chatterjee N., Welch R., Huang W.Y., Hayes R.B. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Cancer Epidemiol. Biomark. Prev. 2007, 16(8):1536-1542.
16. Daugherty S.E., Shugart Y.Y., Platz E.A., Fallin M.D., Isaacs W.B., Pfeiffer R.M., Welch R., Huang W.Y., Reding D., Hayes R.B. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate 2007, 67(14):1487-1497.
17. Driscoli J.S., Melnick N.R., Quinn F.R., Lomax N., Davignon J.P., Ing R., Abott B.J., Congleton G., Dudeck L. Psychotropic drugs as potential antitumor agents: a selective screening study. Cancer Treat. Rep. 1978, 62:45-74.
18. Ekelund J., Lichtermann D., Hovatta I., Ellonen P., Suvisaari J., Terwilliger J.D., et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 2000, 9:1049-1057.
19. Ferdinandusse S., Denis S., IJlst L., Dacremont G., Waterham H.R., Wanders R.J. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J. Lipid Res. 2000, 41(11):1890-1896.
20. Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E., Allen J.T., McLean B.N., Brown A.Y., Vreken P., Waterham H.R., Wanders R.J.A. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat. Genet. 2000, 24:188-191.
21. Ferdinandusse, S., Denis, S., Dacremont, G., Wanders, R.J., 2009. Toxicity of peroxisomal C27-bile acid intermediates. Mol. Genet. Metab. 96 (3), 121-128.
22. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
23. Garver, D.L., Holcomb, J., Mapua, F.M., Wilson, R., Barnes, B., 2001. Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigrees. Schizophr. Res. 52 (3), 145-160.
24. Goldacre M.J., Kurina L.M., Wotton C.J., Yeates D., Seagroat V. Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 2005, 187:334-338.
25. Goldstein J.M., Seidman L.J., Makris N., Ahern T., O'Brien L.M., Caviness V.S., Kennedy D.N., Faraone S.V., Tsuang M.T. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol. Psychiatry 2007, 61:935-946.
26. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Horoutunian V., Feinberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 2001, 98:4746-4751.
27. Hoenicka J., Garrido E., Martínez I., Ponce G., Aragüés M., Rodríguez-Jiménez R., España-Serrano L., Alvira-Botero X., Santos J.L., Rubio G., Jiménez-Arriero M.A., Palomo T. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(1):79-85. PARGPARG.
28. Höistad M., Segal D., Takahashi N., Sakurai T., Buxbaum J.D., Hof P.R. Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. Front. Neuroanat. 2009, 3:1-16.
29. Holliday, E.G., Mowry, B.J., Nyholt, D.R., 2008. A reanalysis of 409 European-Ancestry and African American schizophrenia pedigrees reveals significant linkage to 8p23.3 with evidence of locus heterogeneity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (7), 1080-1088.
30. Honma I., Torigoe T., Hirohashi Y., Kitamura H., Sato E., Masumori N., Tamura Y., Tsukamoto T., Sato N. Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer. J. Transl. Med. 2009, 7:1-11.
31. Jahshan C., Heaton R.K., Golshan S., Cadenhead K.S. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology 2010, 24(1):109-120.
32. Javitt D.C. Sensory processing in schizophrenia: neither simple nor intact. Schizophr. Bull. 2009, 35(6):1059-1064.
33. Jiang Z., Fanger G.R., Woda B.A., Banner B.F., Algate P., Dresser K., Xu J., Chu P.G. Expression of alpha-methylacyl-CoA racemase (P504S) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum. Pathol. 2003, 34(8):792-796.
34. Jiménez J.A., Mancini-Marïe A., Lakis N., Rinaldi M., Mendrek A. Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia. Schizophr. Res. 2010, Apr 10. (Epub ahead of print).
35. Kremen W.S., Vinogradov S., Poole J.H., Schaefer C.A., Deicken R.F., Factor-Litvak P., Brown A.S. Cognitive decline in schizophrenia from childhood to midlife: a 33-year longitudinal birth cohort study. Schizophr. Res. 2010, Feb 10. (Epub ahead of print).
36. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr. Scand. 2007, 116(5):317-333.
37. Leung A., Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. Suppl. 2000, 401:3-38.
38. Levin A.M., Zuhlke K.A., Ray A.M., Cooney K.A., Douglas J.A. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. Prostate 2007, 67(14):1507-1513.
39. Lindamer L.A., Bailey A., Hawthorne W., Folsom D.P., Gilmer T.P., Garcia P., Hough R.L., Jeste D.V. Gender differences in characteristics and service use of public mental health patients with schizophrenia. Psychiatr. Serv. 2003, 54(10):1407-1409.
40. Lindström S., Zheng S.L., Wiklund F., Jonsson B.A., Adami H.O., Bälter K.A., Brookes A.J., Sun J., Chang B.L., Liu W., Li G., Isaacs W.B., Adolfsson J., Grönberg H., Xu J. Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway. Prostate 2006, 66(16):1729-1743.
41. Magri C., Gardella R., Valsecchi P., Barlati S.D., Guizzetti L., Imperadori L., Bonvicini C., Tura G.B., Gennarelli M., Sacchetti E., Barlati S. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(6):745-753.
42. Maurer I., Zierz S., Moller H.J. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr. Res. 2001, 48:125-136.
43. McDonald C., Kenna P., Larkin T. Retinitis pigmentosa and schizophrenia. Eur. Psychiatry 1998, 13(8):423-426.
44. Mendrek A. Reversal of normal cerebral sexual dimorphism in schizophrenia: Evidence and speculations. Med. Hypotheses 2007, 69:896-902.
45. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 2002, 22:2718-2729.
46. Mobley J.A., Leav I., Zielie P., Wotkowitz C., Evans J., Lam Y.W., L'Esperance B.S., Jiang Z., Ho S.M. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol. Biomark. Prev. 2003, 12(8):775-783.
47. Mortensen P.B. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 1992, 85:390-393.
48. Mubiru J.N., Shen-Ong G.L., Valente A.J., Troyer D.A. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer. Gene 2004, 327(1):89-98.
49. Mukherji M., Schofield C.J., Wierzbicki A.S., Jansen G.A., Wanders R.J., Lloyd M.D. The chemical biology of branched-chain lipid metabolism. Prog. Lipid Res. 2003, 42(5):359-376.
50. Nakashima N., Sakai Y., Sakai H., Yanase T., Haji M., Umeda F., Koga S., Hoshita T., Nawata H. A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinius xanthomatosis. J. Lipid Res. 1994, 35:663-668.
51. Paunio, T., Ekelund, J., Varilo, T., Parker, A., Hovatta, I., Turunen, J.A., Rinard, K., Foti, A., Terwilliger, J.D., Juvonen, H., Suvisaari, J., Arajarvi, R., Suokas, J., Partonen, T., Lonnqvist, J., Meyer, J., Peltonen, L., 2001. Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum. Mol. Genet. 10 (26), 3037-3048.
52. Pickard B.S., Thomson P.A., Christoforou A., Evans K.L., Morris S.W., Porteous D.J., Blackwood D.H., Muir W.J. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr. Genet. 2007, 17(3):129-133.
53. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torrey E.F., Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9(7). 684-697, 643.
54. Preacher K.J. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence (Computer software) 2001, Available from http://www.quantpsy.org.
55. Prince J.A., Blennow K., Gottfries C.G., Karlsson I., Oreland L. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 1999, 21(3):372-379.
56. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., Sham P.C. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 2007, 81.
57. Rönicke S., Kruska N., Kahlert S., Reiser G. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes. Neurobiol. Dis. 2009, 36:401-410.
58. Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 2003, 160(2):284-289.
59. Salem J.E., Kring A.M. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin. Psychol. Rev. 1998, 18:795-819.
60. Schwarz E., Prabakaran S., Whitfield P., Major H., Leweke F.M., Koethe D., McKenna P., Bahn S. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J. Proteome Res. 2008, 7(10):4266-4277.
61. Silverman J.M., Greenberg D.A., Altstiel L.D., Siever L.J., Mohs R.C., Smith C.J., Zhou G., Hollander T.E., Yang X.P., Kedache M., Li G., Zaccario M.L., Davis K.L. Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am. J. Med. Genet. 1996, 67:162-171.
62. Sokol R.J., Straka M.S., Dahl R., Devereaux M.W., Yerushalmi B., Gumpricht E., Elkins N., Everson G. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr. Res. 2001, 49:519-531.
63. Suarez, B.K., Duan, J., Sanders, A.R., Hinrichs, A.L., Jin, C.H., Hou, C., Buccola, N.G., Hale, N., Weilbaecher, A.N., Nertney, D.A., Olincy, A., Green, S., Schaffer, A.W., Smith, C.J., Hannah, D.E., Rice, J.P., Cox, N.J., Martinez, M., Mowry, B.J., Amin, F., Silverman, J.M., Black, D.W., Byerley, W.F., Crowe, R.R., Freedman, R., Cloninger, C.R., Levinson, D.F., Gejman, P.V., 2006. Genomewide Linkage Scan of 409 European-Ancestry and African American Families with Schizophrenia: Suggestive Evidence of Linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the Combined Sample. Am. J. Hum. Genet. 78, (2), 315-333.
64. Thomas P., Wood J., Chandra A., Nimgaonkar V.L., Deshpande S.N. Differences among men and women with schizophrenia: a study of US and Indian samples. Psychiatry Investig. 2010, 7(1):9-16.
65. Thompson S.A., Calvin J., Hogg S., Ferdinandusse S., Wanders R.J., Barker R.A. Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. J. Neurol. Neurosurg. Psychiatry 2007, 79(4):448-450.
66. Torrey E.F. Prostate cancer and schizophrenia. Adult Urol. 2006, 68(6):1280-1283.
67. Vazquez Calzada J.L. La distribucion geografica de la poblacion de Puerto Rico. Rev. Cienc. Soc. 1981, 23:93-123.
68. Walsh, T., McClellan, J.M., McCarthy, S.E., Addington, A.M., Pierce, S.B., Cooper, G.M., Nord, A.S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S.M., Rippey, C.F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R.L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E.E., Meltzer, P.S., Nelson, S.F., Singleton, A.B., Lee, M.K., Rapoport, J.L., King, M.C., Sebat, J., 2008. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia. Science 320 (5875), 539-543.
69. Yeap S., Kelly S.P., Sehatpour P., Magno E., Garavan H., Thakore J.H., Foxe J.J. Visual sensory processing deficits in Schizophrenia and their relationship to disease state. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258(5):305-316.
70. Zheng S.L., Chang B.L., Faith D.A., Johnson J.R., Isaacs S.D., Hawkins G.A., Turner A., Wiley K.E., Bleecker E.R., Walsh P.C., Meyers D.A., Isaacs W.B., Xu J. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res. 2002, 62(22):6485-6488.
71. Zhou M., Chinnaiyan A.M., Kleer C.G., Lucas P.C., Rubin M.A. a-Methylacyl-CoA racemase: a novel tumor marker overexpressed in several human cancers and their precursor lesions. Am. J. Surg. Pathol. 2002, 26:926-931.